Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prolonged interval maintenance venom immunotherapy.

A Goldberg1, R E Reisman

  • 1Department of Medicine, State University of New York, Buffalo.

Annals of Allergy
|September 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Polycystic ovary syndrome: associations with cardiovascular disease.

Climacteric : the journal of the International Menopause Society·2023
Same author

Hip arthroplasty practice across the Organisation for Economic Co-operation and Development (OECD) over the last decade.

Annals of the Royal College of Surgeons of England·2023
Same author

The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.

ESMO open·2022
Same author

Evaluation of the 1st metatarso-sesamoid joint using standing CT - The Stanmore classification.

Foot and ankle surgery : official journal of the European Society of Foot and Ankle Surgeons·2018
Same author

Israel transcutaneous bilirubin nomogram predicts significant hyperbilirubinemia.

Journal of perinatology : official journal of the California Perinatal Association·2017
Same author

Use of an anaesthesia workstation barrier device to decrease contamination in a simulated operating room.

British journal of anaesthesia·2017
Same journal

Hay fever; a review of the literature for 1945.

Annals of allergy·2010
Same journal

Nasal and sputum smears.

Annals of allergy·2010
Same journal

Determination of penicillin-susceptible strains of bacteria.

Annals of allergy·2010
Same journal

Fleabite reactions; clinical and experimental observations and effect of histamine-azoprotein therapy.

Annals of allergy·2010
Same journal

D.H.E. 45 (dihydroergotamine) in the treatment of allergic megraine.

Annals of allergy·2010
Same journal

Antigenicity of proteins in relation to allergy.

Annals of allergy·2010
See all related articles

Extending venom immunotherapy intervals to 6, 8, or 12 weeks is safe and effective. This simplified approach maintained clinical and immunologic responses in patients with sting anaphylaxis.

Area of Science:

  • Allergy and Immunology
  • Clinical Medicine

Background:

  • Current guidelines advocate for indefinite venom immunotherapy (VIT) at 4-week intervals for patients with sting anaphylaxis.
  • This regimen can be burdensome for patients, necessitating exploration of simplified treatment schedules.

Purpose of the Study:

  • To evaluate the clinical and immunologic outcomes of extending maintenance venom injections to 6, 8, and 12-week intervals.
  • To determine if a simplified, prolonged interval schedule for VIT is safe and effective.

Main Methods:

  • Twenty-six patients with a history of sting anaphylaxis and positive skin tests were enrolled.
  • Maintenance venom injections were administered at extended intervals (≥6 weeks), starting after an average of 2.3 years on a 4-week schedule.
  • Intervals were progressively extended to 6, 8, and 12 weeks for different patient groups.

Related Experiment Videos

Main Results:

  • No systemic reactions occurred during the extended interval venom immunotherapy.
  • Fourteen mild local reactions were reported, with no necessary dose adjustments.
  • Seventeen re-stings occurred in 12 patients without systemic reactions.
  • Serum venom-specific IgG levels remained stable or increased in 18 patients, while IgE levels showed a trend toward decrease.

Conclusions:

  • Extending the maintenance interval for venom immunotherapy beyond 4 weeks appears to be safe and well-tolerated.
  • Prolonged intervals maintain protective clinical and immunologic responses in patients treated for sting anaphylaxis.
  • This simplification may improve patient adherence and quality of life without compromising therapeutic efficacy.